News and Comments

Like Dendreon (DNDN) Human Genome might have Bottomed

  Monday, January 09, 2012

As expected, Human Genome Sciences (HGSI) will report on progress with the commercialization of Benlysta® (belimumab) during a presentation at the 30th Annual JPMorgan Healthcare Conference in San Francisco. The drug is approved for the treatment of adult patients with active autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy. More...

VERTEX (VRTX): At the Finish Line

  Monday, August 09, 2010

When an investigational drug proves it can eradicate a virus we call it a breakthrough. The nearest to approval of the expected breakthroughs is Vertex’ (VRTX) drug telaprevir, a specific hepatitis C virus protease inhibitor. The drug was a blessing for the infected victims who had it in clinical trials. It brought a miracle happy ending to what seemed to be an endless nightmare of acute liver inflammation, chronic liver inflammation, liver cirrhosis, liver transplant and possible liver cancer. We expected telaprevir to be greeted by the government and insurance companies, which spend ton of money on the HCV liver problems where treatments that do not work are, nevertheless, paid for.  More...

Recent Postings



KERYX (KERX) Sanofi (SNY) Ariad (ARIA) Onyx (ONXX) ARGOS (ARGS) AstraZeneca (AZN) AERIE PHARMACEUTICALS Abbott Laboratories (ABT) Cytokinetics (CYTK) Ionis (IONS) Revlimid (lenolidamide) Seattle Genetics (SGEN) Sanofi (SNA) Biogen Idec (BIIB) TOKAI (TKAOI) Anacor (ANAC) IDERA (IDRA) ABBVIE (ABBV) Idenix (IDIX) Bellicum (BLCM) Human Longevity (HLI) Theravance (THRX) CEMPRA (CEMP) INNOVIVA (INVA) Human Genome Sciences (HGSI) Valeant Pharmaceuticals International (VRX) CompuGen (CGEN) Herceptin C4 Therapeutics Tysabri Mirati Therapeutics (MRTX) Agenus (AGEN Intrexon (XON) HALOZYME (HALO) ARCA (ABIO) Multiple Myeloma Ziofpharm (ZIOP) Array Pharmaceuticals (ARRY) KITE (KITE) Exelixis (EXEL) PTC Therapeutics (PTCT) Vertex (VRTX) RenenxBio (RGNX) REGULUS (RGLS) Biocryst (BCRX) Velcade (bortezomib) Editas (EDIT) Endometrial Cancer ACADIA (ACAD) Theravance Bio Pharma (TBPH) Gilead (GILD) Prosensa (RNA) Jazz Pharmaceuticals (JAZZ) Advaxis (ADXS) Telaprevir Dynavax (DVAX) galapagos (GLPG) Prolor Biotech (PBTH) Regeneron (REGN) Intercept (ICPT) Rapamune SERES THERAPEUTICS (MCRB) Adaptimmune (ADAP) Genentech JUNO (JUNO) NEKTAR (NKTR)) ZALTRAP™ Intermune (ITMN) Pluristem (PSTI) Anadys (ANDS) Roche (ROCHE) Agenus (AGEN) Illumina (ILMN) ImmunoGen (IMGN) BIOMARIN (BMRN) Aimmune Therapeutics (AIMT) Global Cell Therapeutics (GBT) NANTKWEST (NK) GlaxoSmithKline (GSK) Merck (MRK) CRISPR Therapeutics (CRSP) SUNESIS PHARMACEUTICALS (SNSS) ADVENTRIX (ANX) SYNTA (SNTA) Ocular Therapeutix (OCUL) NOVOCURE (NVCR) Alnylam (ALNY) Alder Biopharmaceuticals (ALDR) Inovio (INO) Incyte (INCY) Amgen (AMGN) Benlysta (belimumab) Xoma (XOMA) Zerenex ISIS (ISIS) Vitae Pharmaceuticals (VTAE) Sarepta (SRPT) AGOS (ARGS) Roche (RHHBY) Galena (GALE) GUARDIAN HEALTH Ridaforolimus Bristol-Myers Squibb (BMY) Auspex (ASPX) Micromet (MITI) Elan (ELN) Sanofi-Aventis (SAN) OSI (OSIP) Sequenom (SQNM) MODERNA Spike Therapeutics (ONCE) Dendreon (DNDN) Trastuzumab-DM1 VANDA (VNDA) Sangamo (SGMO)